Diagnosis and Treatment of Early Stage Testicular Cancer

AUA Guideline

Andrew Stephenson, Scott E. Eggener, Eric B. Bass, David M. Chelnick, Siamak Daneshmand, Darren Feldman, Timothy Gilligan, Jose A. Karam, Bradley Leibovich, Stanley L. Liauw, Timothy A. Masterson, Joshua J. Meeks, Phillip Martin Pierorazio, Ritu Sharma, Joel Sheinfeld

Research output: Contribution to journalArticle

Abstract

PURPOSE: Testis cancer is the most common solid malignancy in young males. The purpose of this guideline is to provide a useful reference on the effective evidence-based treatment of early stage testicular cancer. METHODS: The systematic review utilized to inform this guideline was conducted by a methodology team at the Johns Hopkins University Evidence-based Practice Center. The methodology team searched using PubMed®, Embase®, and the Cochrane Central Register of Controlled Trials (CENTRAL) from January 1980 through August 2018. The evidence review team also reviewed relevant systematic reviews and references provided by the panel to identify articles that may have been missed by the database searches. RESULTS: When sufficient evidence existed, the body of evidence was assigned a strength rating of A (high), B (moderate), or C (low). Such evidence-based statements are provided as Strong, Moderate, or Conditional Recommendations. In instances of insufficient evidence, additional guidance is provided as Clinical Principles and Expert Opinions. CONCLUSIONS: This guideline attempts to improve a clinician's ability to evaluate and treat patients with testicular cancer, but higher quality evidence in future trials will be essential to improve level of care for these patients.

Original languageEnglish (US)
Pages (from-to)272-281
Number of pages10
JournalThe Journal of urology
Volume202
Issue number2
DOIs
StatePublished - Aug 1 2019

Fingerprint

Testicular Neoplasms
Guidelines
Evidence-Based Practice
Expert Testimony
PubMed
Patient Care
Therapeutics
Databases
Neoplasms

Keywords

  • carcinoma
  • embryonal
  • seminoma
  • teratoma
  • testicular neoplasms

ASJC Scopus subject areas

  • Urology

Cite this

Stephenson, A., Eggener, S. E., Bass, E. B., Chelnick, D. M., Daneshmand, S., Feldman, D., ... Sheinfeld, J. (2019). Diagnosis and Treatment of Early Stage Testicular Cancer: AUA Guideline. The Journal of urology, 202(2), 272-281. https://doi.org/10.1097/JU.0000000000000318

Diagnosis and Treatment of Early Stage Testicular Cancer : AUA Guideline. / Stephenson, Andrew; Eggener, Scott E.; Bass, Eric B.; Chelnick, David M.; Daneshmand, Siamak; Feldman, Darren; Gilligan, Timothy; Karam, Jose A.; Leibovich, Bradley; Liauw, Stanley L.; Masterson, Timothy A.; Meeks, Joshua J.; Pierorazio, Phillip Martin; Sharma, Ritu; Sheinfeld, Joel.

In: The Journal of urology, Vol. 202, No. 2, 01.08.2019, p. 272-281.

Research output: Contribution to journalArticle

Stephenson, A, Eggener, SE, Bass, EB, Chelnick, DM, Daneshmand, S, Feldman, D, Gilligan, T, Karam, JA, Leibovich, B, Liauw, SL, Masterson, TA, Meeks, JJ, Pierorazio, PM, Sharma, R & Sheinfeld, J 2019, 'Diagnosis and Treatment of Early Stage Testicular Cancer: AUA Guideline', The Journal of urology, vol. 202, no. 2, pp. 272-281. https://doi.org/10.1097/JU.0000000000000318
Stephenson A, Eggener SE, Bass EB, Chelnick DM, Daneshmand S, Feldman D et al. Diagnosis and Treatment of Early Stage Testicular Cancer: AUA Guideline. The Journal of urology. 2019 Aug 1;202(2):272-281. https://doi.org/10.1097/JU.0000000000000318
Stephenson, Andrew ; Eggener, Scott E. ; Bass, Eric B. ; Chelnick, David M. ; Daneshmand, Siamak ; Feldman, Darren ; Gilligan, Timothy ; Karam, Jose A. ; Leibovich, Bradley ; Liauw, Stanley L. ; Masterson, Timothy A. ; Meeks, Joshua J. ; Pierorazio, Phillip Martin ; Sharma, Ritu ; Sheinfeld, Joel. / Diagnosis and Treatment of Early Stage Testicular Cancer : AUA Guideline. In: The Journal of urology. 2019 ; Vol. 202, No. 2. pp. 272-281.
@article{9c86a21590c94021b2fdd8f389d22a9d,
title = "Diagnosis and Treatment of Early Stage Testicular Cancer: AUA Guideline",
abstract = "PURPOSE: Testis cancer is the most common solid malignancy in young males. The purpose of this guideline is to provide a useful reference on the effective evidence-based treatment of early stage testicular cancer. METHODS: The systematic review utilized to inform this guideline was conducted by a methodology team at the Johns Hopkins University Evidence-based Practice Center. The methodology team searched using PubMed{\circledR}, Embase{\circledR}, and the Cochrane Central Register of Controlled Trials (CENTRAL) from January 1980 through August 2018. The evidence review team also reviewed relevant systematic reviews and references provided by the panel to identify articles that may have been missed by the database searches. RESULTS: When sufficient evidence existed, the body of evidence was assigned a strength rating of A (high), B (moderate), or C (low). Such evidence-based statements are provided as Strong, Moderate, or Conditional Recommendations. In instances of insufficient evidence, additional guidance is provided as Clinical Principles and Expert Opinions. CONCLUSIONS: This guideline attempts to improve a clinician's ability to evaluate and treat patients with testicular cancer, but higher quality evidence in future trials will be essential to improve level of care for these patients.",
keywords = "carcinoma, embryonal, seminoma, teratoma, testicular neoplasms",
author = "Andrew Stephenson and Eggener, {Scott E.} and Bass, {Eric B.} and Chelnick, {David M.} and Siamak Daneshmand and Darren Feldman and Timothy Gilligan and Karam, {Jose A.} and Bradley Leibovich and Liauw, {Stanley L.} and Masterson, {Timothy A.} and Meeks, {Joshua J.} and Pierorazio, {Phillip Martin} and Ritu Sharma and Joel Sheinfeld",
year = "2019",
month = "8",
day = "1",
doi = "10.1097/JU.0000000000000318",
language = "English (US)",
volume = "202",
pages = "272--281",
journal = "Journal of Urology",
issn = "0022-5347",
publisher = "Elsevier Inc.",
number = "2",

}

TY - JOUR

T1 - Diagnosis and Treatment of Early Stage Testicular Cancer

T2 - AUA Guideline

AU - Stephenson, Andrew

AU - Eggener, Scott E.

AU - Bass, Eric B.

AU - Chelnick, David M.

AU - Daneshmand, Siamak

AU - Feldman, Darren

AU - Gilligan, Timothy

AU - Karam, Jose A.

AU - Leibovich, Bradley

AU - Liauw, Stanley L.

AU - Masterson, Timothy A.

AU - Meeks, Joshua J.

AU - Pierorazio, Phillip Martin

AU - Sharma, Ritu

AU - Sheinfeld, Joel

PY - 2019/8/1

Y1 - 2019/8/1

N2 - PURPOSE: Testis cancer is the most common solid malignancy in young males. The purpose of this guideline is to provide a useful reference on the effective evidence-based treatment of early stage testicular cancer. METHODS: The systematic review utilized to inform this guideline was conducted by a methodology team at the Johns Hopkins University Evidence-based Practice Center. The methodology team searched using PubMed®, Embase®, and the Cochrane Central Register of Controlled Trials (CENTRAL) from January 1980 through August 2018. The evidence review team also reviewed relevant systematic reviews and references provided by the panel to identify articles that may have been missed by the database searches. RESULTS: When sufficient evidence existed, the body of evidence was assigned a strength rating of A (high), B (moderate), or C (low). Such evidence-based statements are provided as Strong, Moderate, or Conditional Recommendations. In instances of insufficient evidence, additional guidance is provided as Clinical Principles and Expert Opinions. CONCLUSIONS: This guideline attempts to improve a clinician's ability to evaluate and treat patients with testicular cancer, but higher quality evidence in future trials will be essential to improve level of care for these patients.

AB - PURPOSE: Testis cancer is the most common solid malignancy in young males. The purpose of this guideline is to provide a useful reference on the effective evidence-based treatment of early stage testicular cancer. METHODS: The systematic review utilized to inform this guideline was conducted by a methodology team at the Johns Hopkins University Evidence-based Practice Center. The methodology team searched using PubMed®, Embase®, and the Cochrane Central Register of Controlled Trials (CENTRAL) from January 1980 through August 2018. The evidence review team also reviewed relevant systematic reviews and references provided by the panel to identify articles that may have been missed by the database searches. RESULTS: When sufficient evidence existed, the body of evidence was assigned a strength rating of A (high), B (moderate), or C (low). Such evidence-based statements are provided as Strong, Moderate, or Conditional Recommendations. In instances of insufficient evidence, additional guidance is provided as Clinical Principles and Expert Opinions. CONCLUSIONS: This guideline attempts to improve a clinician's ability to evaluate and treat patients with testicular cancer, but higher quality evidence in future trials will be essential to improve level of care for these patients.

KW - carcinoma

KW - embryonal

KW - seminoma

KW - teratoma

KW - testicular neoplasms

UR - http://www.scopus.com/inward/record.url?scp=85069296267&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85069296267&partnerID=8YFLogxK

U2 - 10.1097/JU.0000000000000318

DO - 10.1097/JU.0000000000000318

M3 - Article

VL - 202

SP - 272

EP - 281

JO - Journal of Urology

JF - Journal of Urology

SN - 0022-5347

IS - 2

ER -